Skip to main content

Table 2 Results of the Chi-squared tests on the clinical descriptors of the CAMDA 2017 neuroblastoma dataset

From: Predicting clinical outcome of neuroblastoma patients using an integrative network-based approach

 

Gender

Age

MYCN

Risk

Stage

Prog

Death

Gender

 

1

1

1

1

1

1

Age

0.61

 

5.3e-4

8.8e-28

1.6e-19

3.6e-7

4.8e-11

MYCN

0.50

2.5e-5

 

3.2e-44

7.4e-11

2.3e-8

8.2e-17

Risk

0.09

4.2e-29

1.5e-45

 

1.7e-57

3.4e-25

1.6e-34

Stage

0.43

7.7e-21

3.5e-12

8.2e-59

 

4.2e-21

1.9e-21

Prog

0.58

1.7e-8

1.1e-9

1.6e-26

2.0e-22

 

1.2e-49

Death

0.37

2.3e-12

3.9e-18

7.5e-36

9.0e-23

5.5e-51

 
  1. Results are presented for all pairwise comparisons with Bonferroni corrected P values in the upper triangle, and uncorrected P values in the lower triangle. Notes: Age: age at diagnosis, MYCN: MYCN mutation status, Risk: high-risk, Stage: INSS tumor stage, Prog: progression, Death: death from disease